The DOI matches its Crossref record; 156 of the 156 references it cites were found in a registry or an index.
HIV-1 Antiretroviral Drug Therapy
Open accessAbstract
The most significant advance in the medical management of HIV-1 infection has been the treatment of patients with antiviral drugs, which can suppress HIV-1 replication to undetectable levels. The discovery of HIV-1 as the causative agent of AIDS together with an ever-increasing understanding of the virus replication cycle have been instrumental in this effort by providing researchers with the knowledge and tools required to prosecute drug discovery efforts focused on targeted inhibition with specific pharmacological agents. To date, an arsenal of 24 Food and Drug Administration (FDA)-approved drugs are available for treatment of HIV-1 infections. These drugs are distributed into six distinct classes based on their molecular mechanism and resistance profiles: (1) nucleoside-analog reverse transcriptase inhibitors (NNRTIs), (2) non-nucleoside reverse transcriptase inhibitors (NNRTIs), (3) integrase inhibitors, (4) protease inhibitors (PIs), (5) fusion inhibitors, and (6) coreceptor antagonists. In this article, we will review the basic principles of antiretroviral drug therapy, the mode of drug action, and the factors leading to treatment failure (i.e., drug resistance).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection
Ho, D. D., Neumann, A. U., Perelson, A. S., Chen, W., Leonard, J. M., & Markowitz, M. (1995) · Nature · doi:10.1038/373123a0 · Cited by 4,267
HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor
Feng, Y., Broder, C. C., Kennedy, P. E., & Berger, E. A. (1996) · Science · doi:10.1126/science.272.5263.872 · Cited by 4,172
Identification of a major co-receptor for primary isolates of HIV-1
Deng, H., Liu, R., Ellmeier, W., Choe, S., Unutmaz, D., Burkhart, M., Marzio, P. D., Marmon, S., Sutton, R. E., Hill, C. M., et al. (1996) · Nature · doi:10.1038/381661a0 · Cited by 3,641
The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus
Dalgleish, A. G., Beverley, P. C. L., Clapham, P. R., Crawford, D. H., Greaves, M. F., & Weiss, R. A. (1984) · Nature · doi:10.1038/312763a0 · Cited by 3,533
HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation Time
Perelson, A. S., Neumann, A. U., Markowitz, M., Leonard, J. M., & Ho, D. D. (1996) · Science · doi:10.1126/science.271.5255.1582 · Cited by 3,531
Viral dynamics in human immunodeficiency virus type 1 infection
Wei, X., Ghosh, S. K., Taylor, M. E., Johnson, V. A., Emini, E. A., Deutsch, P., Lifson, J. D., Bonhoeffer, S., Nowak, M. A., Hahn, B. H., et al. (1995) · Nature · doi:10.1038/373117a0 · Cited by 3,260
Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy
Finzi, D., Hermankova, M., Pierson, T., Carruth, L. M., Buck, C., Chaisson, R. E., Quinn, T. C., Chadwick, K., Margolick, J., Brookmeyer, R., et al. (1997) · Science · doi:10.1126/science.278.5341.1295 · Cited by 3,098
CC CKR5: A RANTES, MIP-1α, MIP-1β Receptor as a Fusion Cofactor for Macrophage-Tropic HIV-1
Alkhatib, G., Combadiere, C., Broder, C. C., Feng, Y., Kennedy, P. E., Murphy, P. M., & Berger, E. A. (1996) · Science · doi:10.1126/science.272.5270.1955 · Cited by 2,706
T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV
Klatzmann, D., Champagne, E., Chamaret, S., Gruest, J., Guetard, D., Hercend, T., Gluckman, J.-C., & Montagnier, L. (1984) · Nature · doi:10.1038/312767a0 · Cited by 2,436
Finzi, D., Blankson, J., Siliciano, J. D., Margolick, J. B., Chadwick, K., Pierson, T., Smith, K., Lisziewicz, J., Lori, F., Flexner, C., et al. (1999) · Nature Medicine · doi:10.1038/8394 · Cited by 2,119
HIV Population Dynamics in Vivo: Implications for Genetic Variation, Pathogenesis, and Therapy
Coffin, J. M. (1995) · Science · doi:10.1126/science.7824947 · Cited by 1,981
Crystal structure at 3.5 A resolution of HIV-1 reverse transcriptase complexed with an inhibitor
Kohlstaedt, L. A., Wang, J., Friedman, J. M., Rice, P. A., & Steitz, T. A. (1992) · Science · doi:10.1126/science.1377403 · Cited by 1,914 · cited 6×
“Unlike NRTIs, these non/uncompetitive inhibitors do not inhibit the RT of other lentiviruses such as HIV-2 and simian immunodeficiency virus (SIV) (Kohlstaedt et al. 1992; Witvrouw et al. 1999).”
BackgroundInfluentialMitsuya, H., Weinhold, K. J., Furman, P. A., St Clair, M. H., Lehrman, S. N., Gallo, R. C., Bolognesi, D., Barry, D. W., & Broder, S. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.20.7096 · Cited by 1,866
Doranz, B. J., Rucker, J., Yi, Y., Smyth, R. J., Samson, M., Peiper, S. C., Parmentier, M., Collman, R. G., & Doms, R. W. (1996) · Cell · doi:10.1016/s0092-8674(00)81314-8 · Cited by 1,833
Autran, B., Carcelain, G., Li, T. S., Blanc, C., Mathez, D., Tubiana, R., Katlama, C., Debré, P., & Leibowitch, J. (1997) · Science · doi:10.1126/science.277.5322.112 · Cited by 1,785
Structures of the CXCR4 Chemokine GPCR with Small-Molecule and Cyclic Peptide Antagonists
Wu, B., Chien, E. Y. T., Mol, C. D., Fenalti, G., Liu, W., Katritch, V., Abagyan, R., Brooun, A., Wells, P., Bi, F. C., et al. (2010) · Science · doi:10.1126/science.1194396 · Cited by 1,782
Wei, X., Decker, J. M., Liu, H., Zhang, Z., Arani, R. B., Kilby, J. M., Saag, M. S., Wu, X., Shaw, G. M., & Kappes, J. C. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.6.1896-1905.2002 · Cited by 1,569
Huang, H., Chopra, R., Verdine, G. L., & Harrison, S. C. (1998) · Science · doi:10.1126/science.282.5394.1669 · Cited by 1,420
Furman, P. A., Fyfe, J. A., St Clair, M. H., Weinhold, K., Rideout, J. L., Freeman, G. A., Lehrman, S. N., Bolognesi, D. P., Broder, S., & Mitsuya, H. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.21.8333 · Cited by 1,347
Multiple Mutations in HIV-1 Reverse Transcriptase Confer High-Level Resistance to Zidovudine (AZT)
Larder, B. A., & Kemp, S. D. (1989) · Science · doi:10.1126/science.2479983 · Cited by 1,163
Mansky, L. M., & Temin, H. M. (1995) · Journal of Virology · doi:10.1128/jvi.69.8.5087-5094.1995 · Cited by 1,154
Dorr, P., Westby, M., Dobbs, S., Griffin, P., Irvine, B., Macartney, M., Mori, J., Rickett, G., Smith-Burchnell, C., Napier, C., et al. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.11.4721-4732.2005 · Cited by 1,152
Mitsuya, H., & Broder, S. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.6.1911 · Cited by 1,039
Kilby, J. M., Hopkins, S., Venetta, T. M., DiMassimo, B., Cloud, G. A., Lee, J. Y., Alldredge, L., Hunter, E., Lambert, D., Bolognesi, D., et al. (1998) · Nature Medicine · doi:10.1038/3293 · Cited by 987
In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors
Condra, J. H., Schleif, W. A., Blahy, O. M., Gabryelski, L. J., Graham, D. J., Quintero, J., Rhodes, A., Robbins, H. L., Roth, E., Shivaprakash, M., et al. (1995) · Nature · doi:10.1038/374569a0 · Cited by 974
Wild, C. T., Shugars, D. C., Greenwell, T. K., McDanal, C. B., & Matthews, T. J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.21.9770 · Cited by 931
Enfuvirtide, an HIV-1 Fusion Inhibitor, for Drug-Resistant HIV Infection in North and South America
Lalezari, J. P., Henry, K., O'Hearn, M., Montaner, J. S. G., Piliero, P. J., Trottier, B., Walmsley, S., Cohen, C., Kuritzkes, D. R., Eron, J. J., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035026 · Cited by 914
The molecular basis of the specific anti-influenza action of amantadine.
Hay, A. J., Wolstenholme, A. J., Skehel, J. J., & Smith, M. H. (1985) · The EMBO Journal · doi:10.1002/j.1460-2075.1985.tb04038.x · Cited by 847
Antiviral Activity of 1-Adamantanamine (Amantadine)
Davies, W. L., Grunert, R. R., Haff, R. F., McGahen, J. W., Neumayer, E. M., Paulshock, M., Watts, J. C., Wood, T. R., Hermann, E. C., & Hoffmann, C. E. (1964) · Science · doi:10.1126/science.144.3620.862 · Cited by 838
HIV-1 assembly, budding, and maturation
Sundquist, W. I., & Krausslich, H.-G. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006924 · Cited by 814
Structural definition of a conserved neutralization epitope on HIV-1 gp120
Zhou, T., Xu, L., Dey, B., Hessell, A. J., Van Ryk, D., Xiang, S.-H., Yang, X., Zhang, M.-Y., Zwick, M. B., Arthos, J., et al. (2007) · Nature · doi:10.1038/nature05580 · Cited by 770
Ordered accumulation of mutations in HIV protease confers resistance to ritonavir
Molla, A., Korneyeva, M., Gao, Q., Vasavanonda, S., Schipper, P. J., Mo, H.-M., Markowitz, M., Chernyavskiy, T., Niu, P., Lyons, N., et al. (1996) · Nature Medicine · doi:10.1038/nm0796-760 · Cited by 762
Treatment of Human Immunodeficiency Virus Infection with Saquinavir, Zidovudine, and Zalcitabine
Collier, A. C., Coombs, R. W., Schoenfeld, D. A., Bassett, R. L., Timpone, J., Baruch, A., Jones, M., Facey, K., Whitacre, C., McAuliffe, V. J., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199604183341602 · Cited by 745
Derdeyn, C. A., Decker, J. M., Sfakianos, J. N., Wu, X., O'Brien, W. A., Ratner, L., Kappes, J. C., Shaw, G. M., & Hunter, E. (2000) · Journal of Virology · doi:10.1128/jvi.74.18.8358-8367.2000 · Cited by 742
Wilen, C. B., Tilton, J. C., & Doms, R. W. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006866 · Cited by 654
Potential Mechanism for Sustained Antiretroviral Efficacy of AZT-3TC Combination Therapy
Larder, B. A., Kemp, S. D., & Harrigan, P. R. (1995) · Science · doi:10.1126/science.7542804 · Cited by 623
Brahams, D. (1987) · The Lancet · doi:10.1016/s0140-6736(87)90821-x · Cited by 533
Kozal, M. J., Shah, N., Shen, N., Yang, R., Fucini, R., Merigan, T. C., Richman, D. D., Morris, D., Hubbell, E., Chee, M., et al. (1996) · Nature Medicine · doi:10.1038/nm0796-753 · Cited by 527
Mechanism of Inhibition of HIV-1 Reverse Transcriptase by Nonnucleoside Inhibitors
Spence, R. A., Kati, W. M., Anderson, K. S., & Johnson, K. A. (1995) · Science · doi:10.1126/science.7532321 · Cited by 522
Tantillo, C., Ding, J., Jacobo-Molina, A., Nanni, R. G., Boyer, P. L., Hughes, S. H., Pauwels, R., Andries, K., Janssen, P. A. J., & Arnold, E. (1994) · Journal of Molecular Biology · doi:10.1006/jmbi.1994.1665 · Cited by 518
Hu, W.-S., & Hughes, S. H. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006882 · Cited by 505
HIV Restriction Factors and Mechanisms of Evasion
Malim, M. H., & Bieniasz, P. D. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006940 · Cited by 487
Fujioka, T., Kashiwada, Y., Kilkuskie, R. E., Cosentino, L. M., Ballas, L. M., Jiang, J. B., Janzen, W. P., Chen, I.-S., & Lee, K.-H. (1994) · Journal of Natural Products · doi:10.1021/np50104a008 · Cited by 470
Mechanism of inhibition of HIV-1 reverse transcriptase by non-nucleoside inhibitors
Esnouf, R., Ren, J., Ross, C., Jones, Y., Stammers, D., & Stuart, D. (1995) · Nature Structural & Molecular Biology · doi:10.1038/nsb0495-303 · Cited by 442
Transcriptional and Posttranscriptional Regulation of HIV-1 Gene Expression
Karn, J., & Stoltzfus, C. M. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006916 · Cited by 437
Dragic, T., Trkola, A., Thompson, D. A. D., Cormier, E. G., Kajumo, F. A., Maxwell, E., Lin, S. W., Ying, W., Smith, S. O., Sakmar, T. P., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.090576697 · Cited by 426
Li, F., Goila-Gaur, R., Salzwedel, K., Kilgore, N. R., Reddick, M., Matallana, C., Castillo, A., Zoumplis, D., Martin, D. E., Orenstein, J. M., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2234683100 · Cited by 426
Lederman, M. M., Connick, E., Landay, A., Kuritzkes, D. R., Spritzler, J., St. Clair, M., Kotzin, B. L., Fox, L., Heath Chiozzi, M., Leonard, J. M., et al. (1998) · Journal of Infectious Diseases · doi:10.1086/515591 · Cited by 425
Determinants of Human Immunodeficiency Virus Type 1 Resistance to gp41-Derived Inhibitory Peptides
Rimsky, L. T., Shugars, D. C., & Matthews, T. J. (1998) · Journal of Virology · doi:10.1128/jvi.72.2.986-993.1998 · Cited by 423
Kempf, D. J., Marsh, K. C., Kumar, G., Rodrigues, A. D., Denissen, J. F., McDonald, E., Kukulka, M. J., Hsu, A., Granneman, G. R., Baroldi, P. A., et al. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.3.654 · Cited by 417
Kellam, P., Boucher, C. A., & Larder, B. A. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.5.1934 · Cited by 413
Reeves, J. D., Gallo, S. A., Ahmad, N., Miamidian, J. L., Harvey, P. E., Sharron, M., Pöhlmann, S., Sfakianos, J. N., Derdeyn, C. A., Blumenthal, R., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.252469399 · Cited by 404
Grobler, J. A., Stillmock, K., Hu, B., Witmer, M., Felock, P., Espeseth, A. S., Wolfe, A., Egbertson, M., Bourgeois, M., Melamed, J., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.092056199 · Cited by 399
Self-citationA Synthetic Peptide from HIV-1 gp41 Is a Potent Inhibitor of Virus-Mediated Cell—Cell Fusion
Wild, C., Greenwell, T., & Matthews, T. (1993) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1993.9.1051 · Cited by 398
Komanduri, K. V., Viswanathan, M. N., Wieder, E. D., Schmidt, D. K., Bredt, B. M., Jacobson, M. A., & McCune, J. M. (1998) · Nature Medicine · doi:10.1038/nm0898-953 · Cited by 389
The structure of unliganded reverse transcriptase from the human immunodeficiency virus type 1.
Rodgers, D. W., Gamblin, S. J., Harris, B. A., Ray, S., Culp, J. S., Hellmig, B., Woolf, D. J., Debouck, C., & Harrison, S. C. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.4.1222 · Cited by 378
Hendrix, C. W., Collier, A. C., Lederman, M. M., Schols, D., Pollard, R. B., Brown, S., Jackson, J. B., Coombs, R. W., Glesby, M. J., Flexner, C. W., et al. (2004) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/01.qai.0000137371.80695.ef · Cited by 366
Characterization of human immunodeficiency viruses resistant to oxathiolane-cytosine nucleosides
Schinazi, R. F., Lloyd, R. M., Nguyen, M. H., Cannon, D. L., McMillan, A., Ilksoy, N., Chu, C. K., Liotta, D. C., Bazmi, H. Z., & Mellors, J. W. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.4.875 · Cited by 364
A small molecule HIV-1 inhibitor that targets the HIV-1 envelope and inhibits CD4 receptor binding
Lin, P.-F., Blair, W., Wang, T., Spicer, T., Guo, Q., Zhou, N., Gong, Y.-F., Wang, H.-G. H., Rose, R., Yamanaka, G., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1832214100 · Cited by 357
Boucher, C. A. B., O'Sullivan, E., Mulder, J. W., Ramautarsing, C., Kellam, P., Darby, G., Lange, J. M. A., Goudsmit, J., & Larder, B. A. (1992) · Journal of Infectious Diseases · doi:10.1093/infdis/165.1.105 · Cited by 352
Westby, M., Smith-Burchnell, C., Mori, J., Lewis, M., Mosley, M., Stockdale, M., Dorr, P., Ciaramella, G., & Perros, M. (2007) · Journal of Virology · doi:10.1128/jvi.02006-06 · Cited by 350
Meyer, P. R., Matsuura, S. E., Mian, A. M., So, A. G., & Scott, W. A. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80185-9 · Cited by 349
Arion, D., Kaushik, N., McCormick, S., Borkow, G., & Parniak, M. A. (1998) · Biochemistry · doi:10.1021/bi981200e · Cited by 345
Shimura, K., Kodama, E., Sakagami, Y., Matsuzaki, Y., Watanabe, W., Yamataka, K., Watanabe, Y., Ohata, Y., Doi, S., Sato, M., et al. (2008) · Journal of Virology · doi:10.1128/jvi.01534-07 · Cited by 343
Balzarini, J., Herdewijn, P., & De Clercq, E. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)83322-1 · Cited by 338
Westby, M., Lewis, M., Whitcomb, J., Youle, M., Pozniak, A. L., James, I. T., Jenkins, T. M., Perros, M., & van der Ryst, E. (2006) · Journal of Virology · doi:10.1128/jvi.80.10.4909-4920.2006 · Cited by 337
Hazuda, D. J., Anthony, N. J., Gomez, R. P., Jolly, S. M., Wai, J. S., Zhuang, L., Fisher, T. E., Embrey, M., Guare, J. P., Egbertson, M. S., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402357101 · Cited by 333
Self-citationNovel HIV-1 Integrase Inhibitors Derived from Quinolone Antibiotics
Sato, M., Motomura, T., Aramaki, H., Matsuda, T., Yamashita, M., Ito, Y., Kawakami, H., Matsuzaki, Y., Watanabe, W., Yamataka, K., et al. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm0600139 · Cited by 328
Craigie, R., & Bushman, F. D. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006890 · Cited by 327
Zhang, Y. M., Imamichi, H., Imamichi, T., Lane, H. C., Falloon, J., Vasudevachari, M. B., & Salzman, N. P. (1997) · Journal of Virology · doi:10.1128/jvi.71.9.6662-6670.1997 · Cited by 320
Espeseth, A. S., Felock, P., Wolfe, A., Witmer, M., Grobler, J., Anthony, N., Egbertson, M., Melamed, J. Y., Young, S., Hamill, T., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.200139397 · Cited by 317
Self-citationMolecular mechanisms of retroviral integrase inhibition and the evolution of viral resistance
Hare, S., Vos, A. M., Clayton, R. F., Thuring, J. W., Cummings, M. D., & Cherepanov, P. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1010246107 · Cited by 305
D'Aquila, R. T., Hughes, M. D., Johnson, V. A., Fischl, M. A., Sommadossi, J.-P., Liou, S.-H., Timpone, J., Myers, M., Basgoz, N., Niu, M., et al. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-124-12-199606150-00001 · Cited by 304
HIV-1 escape from a small molecule, CCR5-specific entry inhibitor does not involve CXCR4 use
Trkola, A., Kuhmann, S. E., Strizki, J. M., Maxwell, E., Ketas, T., Morgan, T., Pugach, P., Xu, S., Wojcik, L., Tagat, J., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.012519099 · Cited by 303
Structural Basis of Immune Evasion at the Site of CD4 Attachment on HIV-1 gp120
Chen, L., Do Kwon, Y., Zhou, T., Wu, X., O’Dell, S., Cavacini, L., Hessell, A. J., Pancera, M., Tang, M., Xu, L., et al. (2009) · Science · doi:10.1126/science.1175868 · Cited by 300
Veazey, R. S., Klasse, P. J., Schader, S. M., Hu, Q., Ketas, T. J., Lu, M., Marx, P. A., Dufour, J., Colonno, R. J., Shattock, R. J., et al. (2005) · Nature · doi:10.1038/nature04055 · Cited by 298
Second locus involved in human immunodeficiency virus type 1 resistance to protease inhibitors
Doyon, L., Croteau, G., Thibeault, D., Poulin, F., Pilote, L., & Lamarre, D. (1996) · Journal of Virology · doi:10.1128/jvi.70.6.3763-3769.1996 · Cited by 295
Hsiou, Y., Ding, J., Das, K., Clark, Jr., Hughes, S., & Arnold, E. (1996) · Structure · doi:10.1016/s0969-2126(96)00091-3 · Cited by 289
Integrase Inhibitors and Cellular Immunity Suppress Retroviral Replication in Rhesus Macaques
Hazuda, D. J., Young, S. D., Guare, J. P., Anthony, N. J., Gomez, R. P., Wai, J. S., Vacca, J. P., Handt, L., Motzel, S. L., Klein, H. J., et al. (2004) · Science · doi:10.1126/science.1098632 · Cited by 285
Self-citationSt Clair, M. H., Richards, C. A., Spector, T., Weinhold, K. J., Miller, W. H., Langlois, A. J., & Furman, P. A. (1987) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.31.12.1972 · Cited by 281
Maignan, S., Guilloteau, J.-P., Zhou-Liu, Q., Clément-Mella, C., & Mikol, V. (1998) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.2002 · Cited by 277
Bacheler, L. T., Anton, E. D., Kudish, P., Baker, D., Bunville, J., Krakowski, K., Bolling, L., Aujay, M., Wang, X. V., Ellis, D., et al. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.9.2475-2484.2000 · Cited by 268
Nature, Position, and Frequency of Mutations Made in a Single Cycle of HIV-1 Replication
Abram, M. E., Ferris, A. L., Shao, W., Alvord, W. G., & Hughes, S. H. (2010) · Journal of Virology · doi:10.1128/jvi.00915-10 · Cited by 267
Mammano, F., Petit, C., & Clavel, F. (1998) · Journal of Virology · doi:10.1128/jvi.72.9.7632-7637.1998 · Cited by 264
Selective Excision of AZTMP by Drug-Resistant Human Immunodeficiency Virus Reverse Transcriptase
Boyer, P. L., Sarafianos, S. G., Arnold, E., & Hughes, S. H. (2001) · Journal of Virology · doi:10.1128/jvi.75.10.4832-4842.2001 · Cited by 264
In vitro Selection and Characterization of HIV-1 with Reduced Susceptibility to PMPA
Wainberg, M. A., Miller, M. D., Quan, Y., Salomon, H., Mulato, A. S., Lamy, P. D., Margot, N. A., Anton, K. E., & Cherrington, J. M. (1999) · Antiviral Therapy · doi:10.1177/135965359900400205 · Cited by 247
An inhibitor of the Tat/TAR RNA interaction that effectively suppresses HIV-1 replication
Hamy, F., Felder, E. R., Heizmann, G., Lazdins, J., Aboul-ela, F., Varani, G., Karn, J., & Klimkait, T. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.8.3548 · Cited by 241
Wingfield, W. L., Pollack, D., & Grunert, R. R. (1969) · New England Journal of Medicine · doi:10.1056/nejm196909112811102 · Cited by 234
Lansdon, E. B., Brendza, K. M., Hung, M., Wang, R., Mukund, S., Jin, D., Birkus, G., Kutty, N., & Liu, X. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm1002233 · Cited by 227
Cheng, Y. C., Dutschman, G. E., Bastow, K. F., Sarngadharan, M. G., & Ting, R. Y. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)61637-0 · Cited by 226
Inhibition of HIV Replication in Acute and Chronic Infections in Vitro by a Tat Antagonist
Hsu, M.-C., Schutt, A. D., Holly, M., Slice, L. W., Sherman, M. I., Richman, D. D., Potash, M. J., & Volsky, D. J. (1991) · Science · doi:10.1126/science.1763331 · Cited by 223
Tsamis, F., Gavrilov, S., Kajumo, F., Seibert, C., Kuhmann, S., Ketas, T., Trkola, A., Palani, A., Clader, J. W., Tagat, J. R., et al. (2003) · Journal of Virology · doi:10.1128/jvi.77.9.5201-5208.2003 · Cited by 203
Kuhmann, S. E., Pugach, P., Kunstman, K. J., Taylor, J., Stanfield, R. L., Snyder, A., Strizki, J. M., Riley, J., Baroudy, B. M., Wilson, I. A., et al. (2004) · Journal of Virology · doi:10.1128/jvi.78.6.2790-2807.2004 · Cited by 196
Kuritzkes, D. R., Jacobson, J., Powderly, W. G., Godofsky, E., DeJesus, E., Haas, F., Reimann, K. A., Larson, J. L., Yarbough, P. O., Curt, V., et al. (2004) · The Journal of Infectious Diseases · doi:10.1086/380802 · Cited by 194
Smith, P. F., Ogundele, A., Forrest, A., Wilton, J., Salzwedel, K., Doto, J., Allaway, G. P., & Martin, D. E. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00152-07 · Cited by 190
Malashkevich, V. N., Chan, D. C., Chutkowski, C. T., & Kim, P. S. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.16.9134 · Cited by 188
Molecular Interactions of CCR5 with Major Classes of Small-Molecule Anti-HIV CCR5 Antagonists
Kondru, R., Zhang, J., Ji, C., Mirzadegan, T., Rotstein, D., Sankuratri, S., & Dioszegi, M. (2008) · Molecular Pharmacology · doi:10.1124/mol.107.042101 · Cited by 180
Davidson, A., Leeper, T. C., Athanassiou, Z., Patora-Komisarska, K., Karn, J., Robinson, J. A., & Varani, G. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900629106 · Cited by 178
Strand transfer inhibitors of HIV-1 integrase: Bringing IN a new era of antiretroviral therapy
McColl, D. J., & Chen, X. (2010) · Antiviral Research · doi:10.1016/j.antiviral.2009.11.004 · Cited by 173
Fransen, S., Gupta, S., Danovich, R., Hazuda, D., Miller, M., Witmer, M., Petropoulos, C. J., & Huang, W. (2009) · Journal of Virology · doi:10.1128/jvi.01168-09 · Cited by 172
Self-citationHart, G. J., Orr, D. C., Penn, C. R., Figueiredo, H. T., Gray, N. M., Boehme, R. E., & Cameron, J. M. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.8.1688 · Cited by 170
Goethals, O., Clayton, R., Van Ginderen, M., Vereycken, I., Wagemans, E., Geluykens, P., Dockx, K., Strijbos, R., Smits, V., Vos, A., et al. (2008) · Journal of Virology · doi:10.1128/jvi.00470-08 · Cited by 168
Reeves, J. D., Lee, F.-H., Miamidian, J. L., Jabara, C. B., Juntilla, M. M., & Doms, R. W. (2005) · Journal of Virology · doi:10.1128/jvi.79.8.4991-4999.2005 · Cited by 163
Deval, J., White, K. L., Miller, M. D., Parkin, N. T., Courcambeck, J., Halfon, P., Selmi, B., Boretto, J., & Canard, B. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m308806200 · Cited by 159
Hsu, A., Granneman, G. R., Cao, G., Carothers, L., El-Shourbagy, T., Baroldi, P., Erdman, K., Brown, F., Sun, E., & Leonard, J. M. (1998) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(98)90041-8 · Cited by 158
Margot, N., Isaacson, E., McGowan, I., Cheng, A., Schooley, R. T., & Miller, M. D. (2002) · AIDS · doi:10.1097/00002030-200206140-00004 · Cited by 146
Sluis‐Cremer, N., Temiz, N. A., & Bahar, İ. (2004) · Current HIV Research · doi:10.2174/1570162043351093 · Cited by 146
Veazey, R. S., Klasse, P. J., Ketas, T. J., Reeves, J. D., Piatak, M., Kunstman, K., Kuhmann, S. E., Marx, P. A., Lifson, J. D., Dufour, J., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20031266 · Cited by 145
Marinello, J., Marchand, C., Mott, B. T., Bain, A., Thomas, C. J., & Pommier, Y. G. (2008) · Biochemistry · doi:10.1021/bi800791q · Cited by 142
Nonnucleoside Reverse Transcriptase Inhibitor Resistance
Deeks, S. G. (2001) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00042560-200103011-00004 · Cited by 139
Baldwin, C. E., Sanders, R. W., Deng, Y., Jurriaans, S., Lange, J. M. A., Lu, M., & Berkhout, B. (2004) · Journal of Virology · doi:10.1128/jvi.78.22.12428-12437.2004 · Cited by 136
Parikh, U. M., Bacheler, L. T., Koontz, D. L., & Mellors, J. W. (2006) · Journal of Virology · doi:10.1128/jvi.80.10.4971-4977.2006 · Cited by 130
Marcelin, A., Delaugerre, C., Wirden, M., Viegas, P., Simon, A., Katlama, C., & Cálvez, V. (2003) · Journal of Medical Virology · doi:10.1002/jmv.10550 · Cited by 123
Harrigan, P. R., Kinghorn, I., Bloor, S., Kemp, S. D., Nájera, I., Kohli, A., & Larder, B. A. (1996) · Journal of Virology · doi:10.1128/jvi.70.9.5930-5934.1996 · Cited by 114
Reeves, J. D., Miamidian, J. L., Biscone, M. J., Lee, F.-H., Ahmad, N., Pierson, T. C., & Doms, R. W. (2004) · Journal of Virology · doi:10.1128/jvi.78.10.5476-5485.2004 · Cited by 113
Human Immunodeficiency Virus Reverse Transcriptase
Kim, B., Hathaway, T. R., & Loeb, L. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.9.4872 · Cited by 111
Viral Dynamics in Human Immunodeficiency Virus Type 1 Infection
Benson, C. A. (1995) · Infectious Diseases in Clinical Practice · doi:10.1097/00019048-199505000-00006 · Cited by 111
Tsibris, A. M. N., Sagar, M., Gulick, R. M., Su, Z., Hughes, M. D., Greaves, W. L., Subramanian, M. G., Flexner, C. W., Giguel, F. F., Leopold, K. E., et al. (2008) · Journal of Virology · doi:10.1128/jvi.00444-08 · Cited by 109
Nagashima, K. A., Thompson, D. A. D., Rosenfield, S. I., Maddon, P. J., Dragic, T., & Olson, W. C. (2001) · The Journal of Infectious Diseases · doi:10.1086/319284 · Cited by 105
Marozsan, A. J., Moore, D. M., Lobritz, M. A., Fraundorf, E., Abraha, A., Reeves, J. D., & Arts, E. J. (2005) · Journal of Virology · doi:10.1128/jvi.79.11.7121-7134.2005 · Cited by 104
Self-citationStrong in Vitro Synergy Between the Fusion Inhibitor T-20 and the CXCR4 Blocker AMD-3100
Tremblay, C. C. L., Kollmann, C. S., Giguel, F. F., Chou, T., & Hirsch, M. (2000) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00042560-200010010-00001 · Cited by 98
Activity of non-nucleoside reverse transcriptase inhibitors against HIV-2 and SIV
Witvrouw, M., Pannecouque, C. C., Laethem, K. V., et al. (1999) · AIDS · doi:10.1097/00002030-199908200-00006 · Cited by 97
Naeger, L. K., Margot, N., & Miller, M. D. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.7.2179-2184.2002 · Cited by 93
O'Neil, P. K., Sun, G., Yu, H., Ron, Y., Dougherty, J. P., & Preston, B. D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204774200 · Cited by 92
Baseline Susceptibility of Primary Human Immunodeficiency Virus Type 1 to Entry Inhibitors
Labrosse, B., Labernardière, J., Dam, E., Trouplin, V., Skrabal, K., Clavel, F., & Mammano, F. (2002) · Journal of Virology · doi:10.1128/jvi.77.2.1610-1613.2003 · Cited by 92
Fitness of drug resistant HIV-1: methodology and clinical implications
Quiñones‐Mateu, M. E., & Arts, E. J. (2002) · Drug Resistance Updates · doi:10.1016/s1368-7646(02)00123-1 · Cited by 90
Self-citationDemeter, L. M., Shafer, R. W., Meehan, P. M., Holden‐Wiltse, J., Fischl, M. A., Freimuth, W. W., Para, M. F., & Reichman, R. C. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.3.794-797.2000 · Cited by 89
Resistance to Protease Inhibitors
Miller, V. (2001) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00042560-200103011-00005 · Cited by 88
Baba, M., Miyake, H., Wang, X., Okamoto, M., & Takashima, K. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01079-06 · Cited by 86
Torre, V. S., Marozsan, A. J., Albright, J. L., Collins, K. R., Hartley, O., Offord, R. E., Quiñones‐Mateu, M. E., & Arts, E. J. (2000) · Journal of Virology · doi:10.1128/jvi.74.10.4868-4876.2000 · Cited by 85
Self-citationWhite, K., Chen, J., Feng, J. Y., Margot, N., Ly, J. K., Ray, A. S., MacArthur, H. L., McDermott, M. J., Swaminathan, S., & Miller, M. D. (2006) · Antiviral Therapy · doi:10.1177/135965350601100209 · Cited by 83
Virus Fitness: Concept, Quantification, and Application to HIV Population Dynamics
Quiñones‐Mateu, M. E., & Arts, E. J. (2006) · Current topics in microbiology and immunology · doi:10.1007/3-540-26397-7_4 · Cited by 80
Self-citationGarrido, C., Geretti, A. M., Zahonero, N., Booth, C. L., Strang, A., Soriano, V., & de Mendoza, C. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp423 · Cited by 80
Lalonde, M. S., Lobritz, M. A., Ratcliff, A. N., Chamanian, M., Athanassiou, Z., Tyagi, M., Wong, J. Y., Robinson, J. A., Karn, J., Varani, G., et al. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002038 · Cited by 76
Self-citationHwang, S., Tamilarasu, N., Kibler, K. V., Cao, H., Ali, A., Ping, Y., Jeang, K., & Rana, T. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301749200 · Cited by 74
Doyon, L., Payant, C., Brakier‐Gingras, L., & Lamarre, D. (1998) · Journal of Virology · doi:10.1128/jvi.72.7.6146-6150.1998 · Cited by 72
HIV-1 Evolution under Pressure of Protease Inhibitors: Climbing the Stairs of Viral Fitness
Berkhout, B. (1999) · Journal of Biomedical Science · doi:10.1007/bf02253518 · Cited by 69
Reimann, K. A., Lin, W., BIXLER, S., Browning, B., Ehrenfels, B. N., Lucci, J., Miatkowski, K., Olson, D. L., PARISH, T. H., ROSA, M. D., et al. (1997) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1997.13.933 · Cited by 68
Meyer, P. R., Matsuura, S. E., Tolun, A. A., Pfeifer, I., So, A. G., Mellors, J. W., & Scott, W. A. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.5.1540-1545.2002 · Cited by 61
A Guide to HIV-1 Reverse Transcriptase and Protease Sequencing for Drug Resistance Studies.
Shafer, R. W., Dupnik, K. M., Winters, M. A., & Eshleman, S. H. (2001) · PubMed · Cited by 60
Quan, Y., Gu, Z., Li, X., Li, Z., Morrow, C. D., & Wainberg, M. A. (1996) · Journal of Virology · doi:10.1128/jvi.70.8.5642-5645.1996 · Cited by 59
HIV drug resistance and viral fitness
Clavel, F., Race, E., & Mammano, F. (2000) · Advances in pharmacology · doi:10.1016/s1054-3589(00)49023-x · Cited by 58
Quercia, R., Dam, E., Perez-Bercoff, D., & Clavel, F. (2009) · Journal of Virology · doi:10.1128/jvi.00894-09 · Cited by 56
Damond, F., Lariven, S., Roquebert, B., Males, S., Peytavin, G., Morau, G., Toledano, D., Descamps, D., Brun‐Vézinet, F., & Matheron, S. (2008) · AIDS · doi:10.1097/qad.0b013e3282f51203 · Cited by 55
Singh, I. R., Gorzynski, J. E., Drobysheva, D., Bassit, L., & Schinazi, R. F. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009948 · Cited by 53
Lobritz, M. A., Marozsan, A. J., Troyer, R. M., & Arts, E. J. (2007) · Journal of Virology · doi:10.1128/jvi.02739-06 · Cited by 50
Self-citationMutation and control of the human immunodeficiency virus
Stengel, R. F. (2008) · Mathematical Biosciences · doi:10.1016/j.mbs.2008.03.002 · Cited by 49
Baelen, K. V., Eygen, V. V., Rondelez, E., & Stuyver, L. J. (2008) · AIDS · doi:10.1097/qad.0b013e32830f9703 · Cited by 42
Cupelli, L. A., & Hsu, M. C. (1995) · Journal of Virology · doi:10.1128/jvi.69.4.2640-2643.1995 · Cited by 39
Functional impact of HIV coreceptor-binding site mutations
Biscone, M. J., Miamidian, J. L., Muchiri, J. M., Baik, S., Lee, F.-H., Doms, R. W., & Reeves, J. D. (2006) · Virology · doi:10.1016/j.virol.2006.03.017 · Cited by 35
Park, J., & Morrow, C. D. (1993) · Virology · doi:10.1006/viro.1993.1328 · Cited by 35
Viral Drug Resistance and Fitness
Quiñones‐Mateu, M. E., Moore‐Dudley, D. M., Jegede, O., Weber, J., & Arts, E. J. (2008) · Advances in pharmacology · doi:10.1016/s1054-3589(07)56009-6 · Cited by 33
Self-citationTebit, D. M., Lobritz, M. A., Lalonde, M. S., et al. (2010) · Journal of Virology · doi:10.1128/jvi.00991-10 · Cited by 32
Gao, Y., Paxinos, E. E., Galovich, J., Troyer, R. M., Baird, H., Abreha, M. H., Kityo, C. M., Mugyenyi, P. N., Petropoulos, C. J., & Arts, E. J. (2004) · Journal of Virology · doi:10.1128/jvi.78.10.5390-5401.2004 · Cited by 32
Self-citationEnfuvirtide, an HIV-1 Fusion Inhibitor, for Drug-Resistant HIV Infection in North and South America
(2003) · New England Journal of Medicine · doi:10.1056/nejm200309113491126 · Cited by 26
Yahi, N., Fantini, J., Henry, M., Tourrès, C., & Tamalet, C. (2005) · Journal of Biomedical Science · doi:10.1007/s11373-005-9011-4 · Cited by 18
Cited by
HIV-1 assembly, budding, and maturation
Sundquist, W. I., & Krausslich, H.-G. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006924 · Cited by 814
Craigie, R., & Bushman, F. D. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006890 · Cited by 327
Induction of IL-17 and nonclassical T-cell activation by HIV-Tat protein
Johnson, T. P., Patel, K., Johnson, K. R., Maric, D., Calabresi, P. A., Hasbun, R., & Nath, A. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1308673110 · Cited by 265
Reconstitution and visualization of HIV-1 capsid-dependent replication and integration in vitro
Christensen, D. E., Ganser-Pornillos, B. K., Johnson, J. S., Pornillos, O., & Sundquist, W. I. (2020) · Science · doi:10.1126/science.abc8420 · Cited by 150
LEDGINs inhibit late stage HIV-1 replication by modulating integrase multimerization in the virions
Desimmie, B. A., Schrijvers, R., Demeulemeester, J., Borrenberghs, D., Weydert, C., Thys, W., Vets, S., Van Remoortel, B., Hofkens, J., De Rijck, J., et al. (2013) · Retrovirology · doi:10.1186/1742-4690-10-57 · Cited by 139
Metadata
- Authors
- Arts, E. J., & Hazuda, D. J.
- Venue
- Cold Spring Harbor Perspectives in Medicine
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2012-01-25
- Volume
- 2
- Issue
- 4
- Pages
- a007161-a007161
- ISSN
- 2157-1422 (ISSN-L)
- OpenAlex
- W2098605123
- Cited by
- 851
- References
- 156
- Type
- posted content
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.